<DOC>
	<DOCNO>NCT00174278</DOCNO>
	<brief_summary>To assess effect long-term treatment Genotonorm linear growth</brief_summary>
	<brief_title>Treatment With Recombinant Human Growth Hormone Genotonorm ( Registered ) In Children With Short Stature Secondary</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>All patient benefit one year treatment Genotonorm study 948123014 All patient stop one year include sign write informed consent Endocrine disease , except well substitute hypothyroidism Other severe chronic disease ( e.g . diabetes mellitus , cardiac liver insufficiency )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>